Kane Biotech Inc.

C$0.03As of Sun 8 Nov 2026, 12:00 UTC
TSXV:KNEHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (13.27%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.25
PE TTM —
TSR TTM —
Mkt cap C$6.152M
ROIC (98.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0322
7.22%
8.54%
Hold 9|6|9|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
33.42%
33.24%
31.37%
14.31%
Revenue$M
0.612
0.642
0.652
0.689
9.12%
14.10%
13.97%
16.15%
Peers (US$4.354M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
8.096
0.132
0.121
EBIT/Intx
1.339
0.153
0.136
Own earn%
11.34
(36.62)
(32.29)
Sh yield%
22.26
50.08
47.33
Owners
Insiders/Inst%
5.18
47.48
Short interest%
1.44
SBC / revenue%
4.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
15–24
$1 testx
0.0
Incr. ROIC%
5